Recent Medicare LCD guidelines (L25820) dated 9/1/12 has added ICD-9 cm code 362.07 to the "ICD-9 Codes that are Covered" section for ranibizumab (Lucentis) effective on or after 8/10/12. I've billed this drug code J2778 with ICD-9-CM codes 362.07,362.05,250.50 respectively and the claim has been denied as not following LCD guidelines for medically necessary. What have I missed on this revised guideline?